tiprankstipranks
PMV Pharmaceuticals price target lowered to $15 from $28 at Oppenheimer
The Fly

PMV Pharmaceuticals price target lowered to $15 from $28 at Oppenheimer

Oppenheimer lowered the firm’s price target on PMV Pharmaceuticals to $15 from $28 driven by removal of pipeline programs, extension of timelines for PC14586 and R282W programs, and additional adjustments for increased operating expenses and a dilutive financing. The firm keeps an Outperform rating on the shares.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on PMVP:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles